Sitapati resigned well ahead of the end of his current term, which was earlier extended until October 2031.
The company has appointed Aasif Malbari, its current Group Chief Financial Officer (CFO) and CEO of the Africa business, as MD & CEO for a five-year term.
GCPL has also appointed Vishal Kedia as interim CFO.
Brokerages mixed
The leadership change has triggered a mixed reaction among brokerages, with some cutting their price targets and flagging execution concerns, while others retained their positive stance, citing continuity in the company’s strategic direction.
HSBC downgraded GCPL to ‘Hold’ from its earlier recommendation and cut the price target to ₹1,120.
The brokerage said the sudden departure of Sitapati, despite his term having been extended until 2031, raises uncertainty around execution.
HSBC said that Malbari, the company’s current Group CFO and CEO of the Africa business, will now take over as MD & CEO.
The brokerage also lowered its target price-to-earnings (P/E) multiple to 40x from 45x to factor in the uncertainty around execution.
CLSA maintained its ‘Underperform’ rating on GCPL and reduced its price target to ₹772. The brokerage also cut its target multiple to 32x from 37x.
CLSA said that GCPL has appointed Malbari as CEO with immediate effect following Sitapati’s resignation.
According to the brokerage, management has indicated that the strategic roadmap laid out at the May 2026 Investor Day remains intact, with the focus now shifting towards improving execution and increasing the pace of implementation.
CLSA said a key challenge for GCPL remains improving performance in its two largest categories — personal wash and home insecticides (HI).
In personal wash, the company has limited presence in some of the faster-growing segments, while in HI, the new formulation has not delivered the expected results, the brokerage said.
Citi retained its ‘Buy’ rating on GCPL with a price target of ₹1,350, although it expects the stock to react negatively in the near term following Sitapati’s sudden resignation.
The brokerage said that the company has moved quickly to ensure continuity by appointing Malbari as MD & CEO. Management has also reiterated its FY27 guidance and maintained that the company’s strategic direction remains unchanged.
Citi believes management’s repeated emphasis on ‘candor’ and ‘pace’ could point towards a greater focus on transparency, sharper accountability and faster execution.
The brokerage also said that management commentary suggested promoter expectations were higher in certain areas, particularly liquid vaporizers in India.
While the leadership change could create a near-term sentiment overhang, Citi said it sees no evidence of a strategic reset. Instead, the focus appears to be on improving execution within the existing strategy.
Citi will monitor the appointment of separate heads for the India and international businesses, improvement in liquid vaporizers and whether the renewed focus on execution translates into stronger market share gains and earnings delivery.
Jefferies retained its ‘Buy’ rating on GCPL with a price target of ₹1,400.
The brokerage described Sitapati’s immediate resignation as a surprising development. It noted that the board has appointed Malbari as the new MD & CEO and Kedia as interim CFO.
GCPL also held an investor call to address concerns surrounding the leadership change and outline the new CEO’s priorities.
According to Jefferies, these priorities include stronger execution, greater agility in decision-making, returning the company’s core categories – home insecticides and soaps – to a growth trajectory, and continuing to invest in newer categories and businesses.
The company also aims to drive volume-led growth across regions and gradually convert top-line growth into profit growth, the brokerage said.
Of the 38 analysts that have coverage on GCPL, 30 of them have a ‘Buy’ rating, seven have a ‘Hold’ rating, while one has a ‘Sell’ call on the stock.
GCPL shares ended Tuesday’s session 0.63% lower at ₹1,026.50. The stock has declined nearly 18% so far this year.
